To examine the functional importance of CD43 in protecting leukemia cells from cytolysis by CTLs, we established MLL/AF9-OVA leukemia cells from BM cells of wild-type or CD43-deficient mice, and subjected them to a cytolysis assay with OVA-specific CTLs. This evidence concerns the gene KMT2A and leukemia.